Journal of Lipid Research · 2011 · 242 citations · 37 references
Veterinary MedicineNutritionInflammationLipid BiochemistryMetabolic RegulationHepatic PathophysiologyInsulin ResistanceLiver DiseaseMetabolic DiseaseMetabolic Liver DiseaseMetabolic SyndromeDietary CholesterolHepatic Insulin ResistanceHepatic Lipid AccumulationLiver Disease ComplicationsMetabolic Disease PathologyMetabolic Dysfunction-associated Steatotic Liver Disease FibrosisMetabolic Syndrome DyslipidemiaSerum Alanine Aminotransferase
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, can progress to steatohepatitis (NASH) and advanced liver disease. Mechanisms that underlie this progression remain poorly understood, partly due to lack of good animal models that resemble human NASH. We previously showed that several metabolic syndrome features that develop in LDL receptor-deficient (LDLR−/−) mice fed a diabetogenic diet are worsened by dietary cholesterol. To test whether dietary cholesterol can alter the hepatic phenotype in the metabolic syndrome, we fed LDLR−/− mice a high-fat, high-carbohydrate diabetogenic diet (DD) without or with added cholesterol (DDC). Both groups of mice developed obesity and insulin resistance. Hyperinsulinemia, dyslipidemia, hepatic triglyceride, and alanine aminotransferase (ALT) elevations were greater with DDC. Livers of DD-fed mice showed histological changes resembling NAFLD, including steatosis and modest fibrotic changes; however, DDC-fed animals developed micro- and macrovesicular steatosis, inflammatory cell foci, and fibrosis resembling human NASH. Dietary cholesterol also exacerbated hepatic macrophage infiltration, apoptosis, and oxidative stress. Thus, LDLR−/− mice fed diabetogenic diets may be useful models for studying human NASH. Dietary cholesterol appears to confer a second “hit” that results in a distinct hepatic phenotype characterized by increased inflammation and oxidative stress. Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, can progress to steatohepatitis (NASH) and advanced liver disease. Mechanisms that underlie this progression remain poorly understood, partly due to lack of good animal models that resemble human NASH. We previously showed that several metabolic syndrome features that develop in LDL receptor-deficient (LDLR−/−) mice fed a diabetogenic diet are worsened by dietary cholesterol. To test whether dietary cholesterol can alter the hepatic phenotype in the metabolic syndrome, we fed LDLR−/− mice a high-fat, high-carbohydrate diabetogenic diet (DD) without or with added cholesterol (DDC). Both groups of mice developed obesity and insulin resistance. Hyperinsulinemia, dyslipidemia, hepatic triglyceride, and alanine aminotransferase (ALT) elevations were greater with DDC. Livers of DD-fed mice showed histological changes resembling NAFLD, including steatosis and modest fibrotic changes; however, DDC-fed animals developed micro- and macrovesicular steatosis, inflammatory cell foci, and fibrosis resembling human NASH. Dietary cholesterol also exacerbated hepatic macrophage infiltration, apoptosis, and oxidative stress. Thus, LDLR−/− mice fed diabetogenic diets may be useful models for studying human NASH. Dietary cholesterol appears to confer a second “hit” that results in a distinct hepatic phenotype characterized by increased inflammation and oxidative stress. The obesity epidemic has led to a dramatic increase in the incidence of the metabolic syndrome, insulin resistance, and type 2 diabetes. Nonalcoholic fatty liver disease (NAFLD) is a liver disorder strongly associated with obesity, type 2 diabetes, and insulin resistance (1Marchesini G. Moscatiello S. Di Domizio S. Forlani G. Obesity-associated liver disease.J. Clin. Endocrinol. Metab. 2008; 93: S74-S80Crossref PubMed Scopus (228) Google Scholar). The spectrum of changes in the liver in NAFLD ranges from simple, noninflammatory triglyceride accumulation in hepatocytes (“simple” steatosis or fatty liver) to steatosis with inflammation and fibrosis (steatohepatitis), which occasionally progresses to cirrhosis, end-stage liver disease, and hepatocellular carcinoma (2Farrell G.C. Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology. 2006; 43: S99-S112Crossref PubMed Scopus (1991) Google Scholar). Thus, NAFLD has emerged as a substantial public health concern and is now considered to be the hepatic manifestation of the metabolic syndrome (3Marchesini G. Brizi M. Bianchi G. Tomassetti S. Bugianesi E. Lenzi M. McCullough A.J. Natale S. Forlani G. Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.Diabetes. 2001; 50: 1844-1850Crossref PubMed Scopus (1989) Google Scholar). Triglyceride accumulation in hepatocytes increases vulnerability of the liver to secondary insults through effects of cytokines or oxidative stress (2Farrell G.C. Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology. 2006; 43: S99-S112Crossref PubMed Scopus (1991) Google Scholar). While triglyceride accumulation is believed to occur initially (the “first hit”), it is postulated that progression to more advanced stages of NAFLD, including inflammation, fibrosis (NASH), and cirrhosis, requires a “second hit” superimposed upon hepatic steatosis. This second hit may include genetic susceptibility, dietary factors, or environmental stressors. However, the precise molecular signals that trigger this change have not yet been identified. Several dietary and genetic mouse models have been used to study the pathogenesis of NAFLD. Of these, the methionine-choline deficient (MCD) diet has been used widely to induce a dietary model of NASH in rodents (4Larter C.Z. Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right.J. Gastroenterol. Hepatol. 2008; 23: 1635-1648Crossref PubMed Scopus (272) Google Scholar). This diet rapidly leads to intrahepatic lipid accumulation, with cell injury and cell death due to impaired synthesis of phosphotidylcholine, an essential component of lipoprotein phospholipid (4Larter C.Z. Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right.J. Gastroenterol. Hepatol. 2008; 23: 1635-1648Crossref PubMed Scopus (272) Google Scholar). However, this dietary model results in decreased plasma glucose and insulin levels, improved insulin sensitivity, and weight loss, and therefore, a metabolic phenotype that is very different from that seen in metabolic syndrome in humans. This greatly limits extrapolation of findings in the MCD model to human steatohepatitis. Additional rodent models of NAFLD have involved dietary manipulations in genetically mutant mice, such as leptin-deficient (ob/ob), leptin receptor-deficient (db/db) (5Browning J.D. Horton J.D. Molecular mediators of hepatic steatosis and liver injury.J. Clin. Invest. 2004; 114: 147-152Crossref PubMed Scopus (1768) Google Scholar), and apoE2 knock-in mice (6Shiri-Sverdlov R. Wouters K. van Gorp P.J. Gijbels M.J. Noel B. Buffat L. Staels B. Maeda N. van Bilsen M. Hofker M.H. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.J. Hepatol. 2006; 44: 732-741Abstract Full Text Full Text PDF PubMed Scopus (136) Google Scholar). In these models, high-fat diet feeding induces insulin resistance and triglyceride accumulation in the liver. However, these models lack inflammation and/or fibrosis that are required to fulfill the criteria of NASH (4Larter C.Z. Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right.J. Gastroenterol. Hepatol. 2008; 23: 1635-1648Crossref PubMed Scopus (272) Google Scholar). Models in which caloric overload by intragastric and enteral feeding are used to induce hepatic steatosis and steatohepatitis (7Schattenberg J.M. Galle P.R. Animal models of non-alcoholic steatohepatitis: of mice and man.Dig. Dis. 2010; 28: 247-254Crossref PubMed Scopus (112) Google Scholar) show significant variability in the features of NAFLD observed. Cholesterol feeding can induce several features of the metabolic syndrome, such as dyslipidemia and insulin resistance (8Basciano H. Miller A.E. Naples M. Baker C. Kohen R. Xu E. Su Q. Allister E.M. Wheeler M.B. Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.Am. J. Physiol. Endocrinol. Metab. 2009; 297: E462-E473Crossref PubMed Scopus (77) Google Scholar, 9Subramanian S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). In animal models, dietary cholesterol appears to be an for hepatic steatosis and progression to steatohepatitis K. van Gorp P.J. Gijbels M.J. H. A. van R. Maeda N. Staels B. liver steatosis, leads to hepatic inflammation in mouse models of 2008; PubMed Scopus Google Scholar, M. M. N. K. C. K. as a model of fatty liver disease with Gastroenterol. 2006; PubMed Scopus Google Scholar). However, in cholesterol in diets and lack of of steatosis and/or obesity extrapolation of these animal models to human NASH (8Basciano H. Miller A.E. Naples M. Baker C. Kohen R. Xu E. Su Q. Allister E.M. Wheeler M.B. Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.Am. J. Physiol. Endocrinol. Metab. 2009; 297: E462-E473Crossref PubMed Scopus (77) Google Scholar, K. van Gorp P.J. Gijbels M.J. H. A. van R. Maeda N. Staels B. liver steatosis, leads to hepatic inflammation in mouse models of 2008; PubMed Scopus Google Scholar, M. M. N. K. C. K. as a model of fatty liver disease with Gastroenterol. 2006; PubMed Scopus Google Scholar, N. T. S. H. T. H. M. M. oxidative stress steatohepatitis in mice fed an PubMed Scopus Google Scholar). The LDL receptor-deficient (LDLR−/−) mouse features of the metabolic syndrome fed a diet in and include obesity, insulin resistance, and dyslipidemia, as as inflammation and atherosclerosis S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar, S.A. C. LDL not increases diet-induced obesity and in J. Physiol. Endocrinol. Metab. PubMed Google Scholar). We previously showed that of a of added cholesterol to a diet in and increases insulin resistance, adipose tissue inflammation, inflammation, and atherosclerosis in LDLR−/− mice S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). In the we used LDLR−/− mice fed diabetogenic diets without or with added cholesterol to the effects of dietary cholesterol the hepatic phenotype in the metabolic We show that the LDLR−/− mouse is an rodent model to study changes in the liver in NAFLD, and that dietary cholesterol an in hepatic accumulation, inflammation, and fibrosis of NASH. an increase in lipid in the liver that oxidative stress is involved in the pathogenesis of steatohepatitis in this LDL receptor-deficient mice a were fed rodent a high-fat diet and or a diabetogenic diet with added cholesterol of these diets have been previously S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). were of added and were were in a to diet without added Both high-fat diets were in and for of were in a and and the diets for a of a from the the of Livers were rapidly with and in for histological or in and tissue and lipid of liver in and in and This by the Animal and of the of and liver cholesterol and were insulin an aminotransferase (ALT) an through the the of fatty were test lipid a J. M. for the and of from animal Full Text PDF PubMed Google Scholar). in from of as previously H. N. K. for lipid in animal by PubMed Scopus Google Scholar). in were and with and and or for histological by a in a were in liver a fibrosis in of the liver. for and fibrosis of liver cell the to the In To the of liver were by the of in are as of from of liver tissue to the 2 of and by by the in and for were from of were with used as the and the of the of the were not in the animal were in of with and by of an and The were with an of for to with in for The by the of 2 of were with and the were and were to for and an were an with an of fatty and were by of the of and The of the fatty and were to fatty and by of the to and to to and its were to the fatty and diet were in a in and The with of as an to the the and to were added to the to in the were with and The and with in and for The and in for by were and are as and with used to used to considered We previously showed that LDLR−/− mice fed a diabetogenic diet (DD) for and developed dyslipidemia, which as and cholesterol S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). of dietary cholesterol worsened without In the we these findings and weight in the and were in both and groups in animals and were not different the obese LDLR−/− animals the and fatty were increased in both diabetogenic groups were in the triglyceride increased in animals in the animals cholesterol were in the with hepatic triglyceride and plasma Thus, several metabolic that have been in the of NAFLD were worsened by dietary cholesterol in obese LDLR−/− in mice the different weight of weight weight fatty cholesterol in a To the of dietary cholesterol hepatic we histological of the In the features required for a of NASH in include macrovesicular steatosis inflammation, fibrosis hepatocytes and hepatic and E.M. M. C. M.J. A. and of a histological for fatty liver PubMed Scopus Google Scholar). of and liver from animals liver without lipid accumulation in In the macrovesicular steatosis in a and fibrosis were seen to a in the In the steatosis both macrovesicular as as with a inflammatory cell and and fibrosis were seen to a greater in the of fibrosis in increased fibrotic in the and of a feature seen in human obese LDLR−/− mice showed several features of human which were with dietary cholesterol. inflammation, a of is widely believed to be through cytokines from hepatocytes or as have been as a in insulin resistance, we the effects of dietary cholesterol hepatic of the and were increased in the of the cytokines and also were increased in the of a for and hepatic in both groups and are of that are in inflammatory A. Han C.Y. The and inflammatory or mediators of Full Text Full Text PDF PubMed Scopus Google Scholar) and have the J. PubMed Scopus Google Scholar). of increased in both groups significant in the The in the not of the of animals of liver for the showed increased in the greater in the these findings that the of dietary cholesterol induces a greater of inflammation in the liver. these findings changes that we showed previously in adipose tissue S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar), that hepatic inflammation is an component of diet-induced obesity in this mouse To the effects of dietary cholesterol hepatic triglyceride accumulation, we the hepatic of involved in fatty in the liver. were in of or involved in fatty of a that involved in in both obese groups of it in the due to the of animals of the which the in triglyceride in both groups of obese animals of a that cholesterol the groups In to several A. J. T. S. M. A. in human J. Physiol. Physiol. 2008; PubMed Scopus Google Scholar, M. H. hepatic to dyslipidemia associated with diet-induced PubMed Scopus Google Scholar), we were not to show an increase in liver not fatty has been in the pathogenesis of fatty liver and liver liver disease and fatty J. Physiol. Physiol. 2006; PubMed Scopus Google Scholar). of a fatty involved in in the were increased in and increased in the of the hepatic fatty in this in occur with NAFLD secondary to hepatocellular inflammation and were increased in the more in the a greater of injury with the of dietary cholesterol. strongly with hepatic triglyceride a in the of mice fed which increased in the of mice The of with hepatic and with stress with increased of has been in animal models and human NASH S. T. T. H. K. K. In of lipid and oxidative in non-alcoholic fatty liver Hepatol. Full Text Full Text PDF PubMed Scopus Google Scholar, S. H. H. K. to PubMed Scopus Google Scholar). in the liver are of and oxidative of the fatty in and are inflammatory of and for the of of and M. E. as a for lipid in PubMed Scopus Google Scholar). To a of lipid we distinct fatty including and and fatty from liver. of and of were increased in the were with hepatic triglyceride elevations in several were in both obese of from of in both and groups in the not a of lipid also increased in the not findings with Cholesterol oxidative by or of also have been in and liver dietary cholesterol can be by we liver and dietary such as and of these were in the diet not However, hepatic of and and were increased in the of mice both diabetogenic with in the these results of increased of oxidative stress in the obese LDLR−/− mice that the diabetogenic diet with added cholesterol. We previously showed that the of cholesterol to a diet in and worsens adipose tissue inflammation, insulin resistance, and inflammation in LDLR−/− mice S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). Thus, this is a good model to study features of the metabolic In the we used the LDLR−/− mouse to the of these diets the hepatic phenotype of the metabolic fed the diabetogenic diet without added cholesterol developed histological changes that features seen in human NAFLD, such as inflammation and of dietary cholesterol in worsened hepatic inflammation and dietary cholesterol as an of the of changes that occur with progression of NAFLD. of NAFLD in mouse models not seen in (4Larter C.Z. Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right.J. Gastroenterol. Hepatol. 2008; 23: 1635-1648Crossref PubMed Scopus (272) Google Scholar). the diet used to study NAFLD in mice results in hepatic fibrosis and inflammation, this model not human NASH as mice this diet weight and more insulin The methionine-choline deficient dietary model of steatohepatitis not insulin Hepatol. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), in to the phenotype that in the metabolic by high-fat and intragastric feeding to have features of and to results its (4Larter C.Z. Yeh M.M. Animal models of NASH: getting both pathology and metabolic context right.J. Gastroenterol. Hepatol. 2008; 23: 1635-1648Crossref PubMed Scopus (272) Google Scholar). LDLR−/− mice develop obesity, dyslipidemia, and insulin resistance to that seen in the metabolic syndrome in humans. We now show that inflammatory changes also occur in the to we previously showed in adipose tissue S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). In with a M.J. and steatohepatitis in lipoprotein 2010; PubMed Scopus Google Scholar), we several features of human NAFLD in LDLR−/− mice fed a diabetogenic with by the of dietary cholesterol. Thus, LDLR−/− mice that develop obesity a diet in and with added cholesterol have histological features that with a metabolic phenotype to that seen in obese humans. This model therefore, for studying the pathogenesis of liver disease in the metabolic syndrome, the of dietary cholesterol. feature in obesity associated with insulin resistance is adipose tissue inflammation, with accumulation of in in mice and M. M. is associated with macrophage accumulation in adipose Clin. Invest. PubMed Scopus Google Scholar, H. Q. G. J. A. inflammation in a in the of insulin Clin. Invest. PubMed Scopus Google Scholar). We previously showed that in the adipose tissue of LDLR−/− mice fed these diabetogenic diets and that the of macrophage accumulation and adipose tissue inflammatory were increased by cholesterol of the diabetogenic diet S. Han C.Y. Chiba T. McMillen T.S. Wang S.A. Haw 3rd, A. Kirk E.A. O'Brien K.D. Chait A. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient 2008; 28: PubMed Scopus Google Scholar). we that changes occur in the of obese LDLR−/− mice, the that to inflammation and insulin resistance be in both adipose tissue and liver. In this obese mice showed significant inflammatory changes in the including increased of and an increase in the of While these effects were modest in mice that the diabetogenic were by of cholesterol to the We also increased of a macrophage were increased in both and that may a in liver macrophage accumulation not decreased in of mice, these mice were not obese have fatty or insulin resistance not steatosis or inflammation in of mice fed a Invest. Scopus Google Scholar). the has been for progression of steatosis to NASH a of 114: Full Text Full Text PDF PubMed Scopus Google Scholar). Triglyceride accumulation in hepatocytes is widely as an for the of NAFLD, which to injury triglyceride synthesis and fatty liver 2008; PubMed Scopus Google Scholar). Dietary cholesterol has been as a second hit (8Basciano H. Miller A.E. Naples M. Baker C. Kohen R. Xu E. Su Q. Allister E.M. Wheeler M.B. Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.Am. J. Physiol. Endocrinol. Metab. 2009; 297: E462-E473Crossref PubMed Scopus (77) Google Scholar, K. van Gorp P.J. Gijbels M.J. H. A. van R. Maeda N. Staels B. liver steatosis, leads to hepatic inflammation in mouse models of 2008; PubMed Scopus Google Scholar). second insults that have been in inflammatory liver and seen in NASH include oxidative and of cytokines (5Browning J.D. Horton J.D. Molecular mediators of hepatic steatosis and liver injury.J. Clin. Invest. 2004; 114: 147-152Crossref PubMed Scopus (1768) Google Scholar). In this we have to several of these are increased in the metabolic syndrome and NAFLD in and plasma with disease K.D. and metabolic in the of Dis. 2001; PubMed Scopus Google Scholar). In plasma with hepatic triglyceride levels, that are an of hepatic in rodents and have fatty as an to the pathogenesis of insulin resistance and NASH A. J. T. S. M. A. in human J. Physiol. Physiol. 2008; PubMed Scopus Google Scholar, M. H. hepatic to dyslipidemia associated with diet-induced PubMed Scopus Google Scholar). However, we were to these findings in of the findings in the study is that changes in the liver were exacerbated by the of cholesterol to the Dietary cholesterol has been to induce hepatic inflammation in several While groups have the of dietary cholesterol in several and of feeding in mice dietary cholesterol showed that hepatic inflammation developed without steatosis K. van Gorp P.J. Gijbels M.J. H. A. van R. Maeda N. Staels B. liver steatosis, leads to hepatic inflammation in mouse models of 2008; PubMed Scopus Google Scholar). model of diet-induced obesity showed steatosis and insulin resistance without significant weight (8Basciano H. Miller A.E. Naples M. Baker C. Kohen R. Xu E. Su Q. Allister E.M. Wheeler M.B. Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis.Am. J. Physiol. Endocrinol. Metab. 2009; 297: E462-E473Crossref PubMed Scopus (77) Google Scholar). fed a high-fat diet with cholesterol showed increased steatosis, inflammation, and changes L. Wang of high-fat, non-alcoholic steatohepatitis with fibrosis in Dis. 2010; PubMed Scopus Google Scholar). of cholesterol in the diet weight and were to the in with N. T. S. H. T. H. M. M. oxidative stress steatohepatitis in mice fed an PubMed Scopus Google Scholar). We used the LDLR−/− mouse model fed a diabetogenic diet without or with an that to be and not weight of of cholesterol to that be more to the metabolic syndrome in humans. have that cholesterol feeding a of in hepatic metabolic and inflammatory upon the of cholesterol in the diet R. L. van M.J. S. and liver inflammation by increased dietary cholesterol a and PubMed Scopus Google Scholar, L. J. M. S. K. Cholesterol and of an diet induce distinct stages of hepatic inflammatory Full Text Full Text PDF PubMed Scopus Google Scholar). The by which dietary cholesterol induces hepatic inflammation and oxidative stress in study are and of cholesterol is study showed that an for liver injury the of to injury M. A. A. J. A. C. C. cholesterol to and Metab. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). include B. M. G. E.A. is the of in PubMed Scopus Google Scholar). cell death is a feature of liver injury H. Molecular of in fatty liver Dis. 2008; 28: PubMed Scopus Google Scholar), and with disease in NASH A.E. A. M. K.D. and are features of human Full Text Full Text PDF PubMed Scopus Google Scholar). In in of mice both diabetogenic dietary cholesterol increased Dietary cholesterol also increased which can trigger a and induce H. fatty induce 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). stress is a to disease progression in NAFLD C. M. stress in the pathogenesis of fatty liver disease, in fed with a PubMed Scopus Google Scholar, T. A. A. R. R. C. stress and cell accumulation in mice and with and fatty liver J. Full Text Full Text PDF PubMed Scopus Google Scholar, R. J. J. stress and of hepatic fatty may to fatty liver 2004; PubMed Scopus Google Scholar). We a significant increase in of lipid such as and in mice fed dietary cholesterol. of such lipid or are of oxidative stress A.E. R. L. M. R. of lipid in human fatty liver disease and 2010; Full Text Full Text PDF PubMed Scopus Google Scholar) and the and the in mouse increased of and have been in human NASH A.E. R. L. M. R. of lipid in human fatty liver disease and 2010; Full Text Full Text PDF PubMed Scopus Google Scholar). In that can in K.D. J.M. of cell and by and in 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). We also increased and a in from lipid The hepatic and triglyceride for a for Thus, these findings are with the that both and oxidative to the of fatty in this In to these fatty cholesterol can to Early that substantial of can be in the diet of lipid in PubMed Scopus Google however, can also be by of cholesterol to a of cholesterol A.J. and and in cholesterol 2009; PubMed Scopus Google Scholar). In we increased of several in liver from both groups of mice fed the diabetogenic we were to in the have been to be N. and J. 2010; PubMed Scopus Google Scholar), and accumulation of in the liver may have to the increased seen in In that can trigger and changes in hepatocytes N. M. M. A. R. A. J. J. A. to exacerbated liver injury in of J. Physiol. Physiol. 2009; PubMed Scopus Google Scholar). mice have hepatic and increased to liver injury and fibrosis N. M. M. A. R. A. J. J. A. to exacerbated liver injury in of J. Physiol. Physiol. 2009; PubMed Scopus Google Scholar). Thus, dietary cholesterol may have to the fibrosis seen in these mice by to in In the LDLR−/− mouse has seen in human therefore, may as a model for studying the and changes that occur in the liver in We also showed that dietary cholesterol exacerbated the progression from steatosis to steatohepatitis by hepatic While the in this in dietary cholesterol appears to a in both triglyceride accumulation and which may be a to macrophage accumulation and hepatic inflammation, as changes in the liver seen in adipose from steatosis to steatohepatitis be the of a of factors, such as increased fatty and of which to inflammatory changes and in the liver. alanine aminotransferase diabetogenic diet diabetogenic diet with cholesterol and LDL non-alcoholic fatty liver disease non-alcoholic steatohepatitis
37
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
Obesity is associated with macrophage accumulation in adipose tissue
Stuart P. Weisberg, Daniel McCann, Manisha Desai et al. · Journal of Clinical Investigation · 2003 · 8.6K citations · Full text
Obesity is associated with macrophage accumulation in adipose tissue
Stuart P. Weisberg, Daniel McCann, Manisha Desai et al. · Journal of Clinical Investigation · 2003 · 8.3K citations · Full text